Correlation Between 23Andme Holding and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Inovio Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Inovio Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Inovio Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Inovio is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Inovio Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Inovio Pharmaceuticals. In addition to that, 23Andme Holding is 1.01 times more volatile than Inovio Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 2,076 in Inovio Pharmaceuticals on August 30, 2024 and sell it today you would lose (1,657) from holding Inovio Pharmaceuticals or give up 79.82% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. Inovio Pharmaceuticals
Performance |
Timeline |
23Andme Holding |
Inovio Pharmaceuticals |
23Andme Holding and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Inovio Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |